Htoo PT, Tesfaye H, Schneeweiss S, Wexler DJ, et al. Comparative healthcare resource utilization and costs of empagliflozin and GLP-1 receptor agonists in type 2 diabetes. Diabetes Obes Metab 2025 Oct 15. doi: 10.1111/dom.70195.
PMID: 41090391